APA

Smalley K. S. M., Contractor R., Haass N. K., Kulp A. N., Atilla-Gokcumen G. E., Williams D. S., Bregman H., Flaherty K. T., Soengas M. S., Meggers E. & Herlyn M. (20070130). An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. : Cancer research.

Chicago

Smalley Keiran S M, Contractor Rooha, Haass Nikolas K, Kulp Angela N, Atilla-Gokcumen G Ekin, Williams Douglas S, Bregman Howard, Flaherty Keith T, Soengas Maria S, Meggers Eric and Herlyn Meenhard. 20070130. An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. : Cancer research.

Harvard

Smalley K. S. M., Contractor R., Haass N. K., Kulp A. N., Atilla-Gokcumen G. E., Williams D. S., Bregman H., Flaherty K. T., Soengas M. S., Meggers E. and Herlyn M. (20070130). An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. : Cancer research.

MLA

Smalley Keiran S M, Contractor Rooha, Haass Nikolas K, Kulp Angela N, Atilla-Gokcumen G Ekin, Williams Douglas S, Bregman Howard, Flaherty Keith T, Soengas Maria S, Meggers Eric and Herlyn Meenhard. An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. : Cancer research. 20070130.